• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人补体经典途径的可溶性C3前转化酶和转化酶。体外稳定条件。

Soluble C3 proconvertase and convertase of the classical pathway of human complement. Conditions of stabilization in vitro.

作者信息

Villiers M B, Thielens N M, Colomb M G

出版信息

Biochem J. 1985 Mar 1;226(2):429-36. doi: 10.1042/bj2260429.

DOI:10.1042/bj2260429
PMID:3922352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1144729/
Abstract

Soluble classical-pathway C3 convertase and proconvertase were prepared from purified C4b-C2ox complex in the presence of Ni2+; the two complexes, stable for at least 15 h at 4 degrees C, were isolated by sucrose-density-gradient ultracentrifugation. The C3 convertase alone was able to cleave C3, and its decay was accelerated in the presence of C4-binding protein. The individual roles of Ni2+ and I2 treatment of C2 in the stabilization of the complexes seemed to be different and additive. 63Ni2+ binding coupled to h.p.l.c. analysis showed that 63Ni2+ bound only to the C2ox proteolytic fragment a (1 mol/mol) with a Kd of 26 microM. Competition studies between Ni2+ and Mg2+ indicated that only half of the Ni2+ bound to the C3 convertase was removed by Mg2+, whereas, in the same conditions, Ni2+ bound to C2ox proteolytic fragment a was not displaced, suggesting the presence of two sets of sites on the convertase. EDTA prevented the formation of both C3 convertase and proconvertase; EDTA had no effect on the preformed C3 convertase, whereas it dissociated the preformed proconvertase.

摘要

在Ni2+存在的情况下,从纯化的C4b - C2ox复合物中制备可溶性经典途径C3转化酶和前转化酶;这两种复合物在4℃下至少稳定15小时,通过蔗糖密度梯度超速离心法分离。单独的C3转化酶能够裂解C3,并且在C4结合蛋白存在的情况下其衰变加速。Ni2+和I2处理C2在复合物稳定中的各自作用似乎不同且具有加和性。与高效液相色谱分析相结合的63Ni2+结合表明,63Ni2+仅以26 microM的Kd与C2ox蛋白水解片段a(1摩尔/摩尔)结合。Ni2+和Mg2+之间的竞争研究表明,只有一半与C3转化酶结合的Ni2+被Mg2+去除,而在相同条件下,与C2ox蛋白水解片段a结合 的Ni2+未被取代,这表明转化酶上存在两组位点。EDTA阻止C3转化酶和前转化酶的形成;EDTA对预先形成的C3转化酶没有影响,而它会使预先形成的前转化酶解离。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/1144729/1fcd98c4e7b7/biochemj00308-0093-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/1144729/1fcd98c4e7b7/biochemj00308-0093-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/780a/1144729/1fcd98c4e7b7/biochemj00308-0093-a.jpg

相似文献

1
Soluble C3 proconvertase and convertase of the classical pathway of human complement. Conditions of stabilization in vitro.人补体经典途径的可溶性C3前转化酶和转化酶。体外稳定条件。
Biochem J. 1985 Mar 1;226(2):429-36. doi: 10.1042/bj2260429.
2
A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).用于研究人类补体C3转化酶(经典途径)组装与调节的模型系统。
Eur J Immunol. 1986 Jun;16(6):617-22. doi: 10.1002/eji.1830160606.
3
Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.由肾炎因子稳定的经典和替代补体途径C3转化酶免受人类C3b受体介导的衰变作用。
Eur J Immunol. 1984 Dec;14(12):1111-4. doi: 10.1002/eji.1830141209.
4
Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.C4肾炎因子的作用机制。C3转化酶经典途径的失调。
J Exp Med. 1981 Jul 1;154(1):1-12. doi: 10.1084/jem.154.1.1.
5
C3 convertase of the alternative complement pathway. Demonstration of an active, stable C3b, Bb (Ni) complex.替代补体途径的C3转化酶。活性稳定的C3b、Bb(镍)复合物的证明。
J Biol Chem. 1983 Jun 25;258(12):7411-5.
6
The low C5 convertase activity of the C4A6 allotype of human complement component C4.人类补体成分C4的C4A6同种异型的低C5转化酶活性。
Biochem J. 1989 Aug 1;261(3):743-8. doi: 10.1042/bj2610743.
7
Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.血浆蛋白C4结合蛋白和C3b灭活剂对经典途径C3转化酶的调节作用。
Proc Natl Acad Sci U S A. 1979 Dec;76(12):6596-600. doi: 10.1073/pnas.76.12.6596.
8
Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.补体替代途径C3转化酶成分备解素与B因子之间相互作用的分析。
Biochem J. 1988 Aug 1;253(3):667-75. doi: 10.1042/bj2530667.
9
C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.人补体C3转化酶:用镍而非镁生成的酶的形成增强及稳定性提高。
J Immunol. 1982 Dec;129(6):2603-7.
10
Characterization of the initial C3 convertase of the alternative pathway of human complement.人类补体替代途径初始C3转化酶的特性分析。
J Immunol. 1984 Mar;132(3):1430-4.

引用本文的文献

1
Analysis of complement deposition and processing on Chlamydia trachomatis.分析沙眼衣原体上补体的沉积和加工。
Med Microbiol Immunol. 2021 Feb;210(1):13-32. doi: 10.1007/s00430-020-00695-x. Epub 2020 Nov 18.
2
The structural basis for inhibition of the classical and lectin complement pathways by S. aureus extracellular adherence protein.金黄色葡萄球菌细胞外黏附蛋白对经典和凝集素补体途径的抑制作用的结构基础。
Protein Sci. 2017 Aug;26(8):1595-1608. doi: 10.1002/pro.3195. Epub 2017 May 31.
3
Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases.

本文引用的文献

1
MEASUREMENT OF LOW ENERGY BETA-EMITTERS IN AQUEOUS SOLUTION BY LIQUID SCINTILLATION COUNTING OF EMULSIONS.通过乳液的液体闪烁计数法测量水溶液中的低能β发射体。
Anal Chem. 1965 Jun;37:854-7. doi: 10.1021/ac60226a017.
2
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.圆盘电泳。II. 方法及其在人血清蛋白中的应用。
Ann N Y Acad Sci. 1964 Dec 28;121:404-27. doi: 10.1111/j.1749-6632.1964.tb14213.x.
3
A method for determining the sedimentation behavior of enzymes: application to protein mixtures.一种测定酶沉降行为的方法:应用于蛋白质混合物
补体C2及其C4复合物的溶液结构提出了补体前转化酶控制和激活的途径特异性机制。
J Biol Chem. 2016 Aug 5;291(32):16494-507. doi: 10.1074/jbc.M116.722017. Epub 2016 Jun 1.
4
Effect of sodium chloride concentration on fluid-phase assembly and stability of the C3 convertase of the classical pathway of the complement system.氯化钠浓度对补体系统经典途径C3转化酶液相组装及稳定性的影响
Biochem J. 1990 Nov 1;271(3):749-54. doi: 10.1042/bj2710749.
J Biol Chem. 1961 May;236:1372-9.
4
A newly described control mechanism of complement activation in patients with mixed cryoglobulinemia (cryoglobulins and complement).混合性冷球蛋白血症(冷球蛋白与补体)患者中一种新描述的补体激活控制机制。
J Invest Dermatol. 1980 May;74(5):328-32. doi: 10.1111/1523-1747.ep12543575.
5
Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.人补体第四成分(C4)和第五成分(C5)的不稳定结合位点与红细胞细胞膜之间的相互作用。
J Immunol. 1980 Aug;125(2):634-9.
6
C4 binding to artificial systems.C4与人工系统的结合。
FEBS Lett. 1981 Oct 12;133(1):151-6. doi: 10.1016/0014-5793(81)80493-0.
7
The covalent-binding reaction of complement component C3.补体成分C3的共价结合反应
Biochem J. 1981 Jan 1;193(1):115-27. doi: 10.1042/bj1930115.
8
Activation of the early components of the classical complement pathway under physiologic conditions.在生理条件下经典补体途径早期成分的激活。
J Immunol. 1981 May;126(5):1769-73.
9
Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.C4肾炎因子的作用机制。C3转化酶经典途径的失调。
J Exp Med. 1981 Jul 1;154(1):1-12. doi: 10.1084/jem.154.1.1.
10
Function of the activated fourth component of complement (C4b) in activation of C2.补体激活的第四成分(C4b)在C2激活中的作用。
FEBS Lett. 1982 Aug 2;144(2):195-8. doi: 10.1016/0014-5793(82)80636-4.